Quantum Biopharma (QNTM) Net Cash Flow (2019 - 2026)

Quantum Biopharma's Net Cash Flow history runs 7 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 198.34% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $1.8 million (down 63.84% YoY), while the FY2025 annual figure was -$4.1 million, down 226.3% from the prior year.
• Net Cash Flow came in at $2.4 million for Q1 2026 at Quantum Biopharma, up from $1.5 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $9.7 million in Q2 2022 to a low of -$42.5 million in Q4 2022.
• A 4-year average of -$1.0 million and a median of $1.5 million in 2025 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow sank 153.26% in 2025 and jumped 198.34% in 2026, its largest moves.
• Quantum Biopharma's Net Cash Flow stood at -$42.5 million in 2022, then soared by 106.76% to $2.9 million in 2024, then plunged by 49.25% to $1.5 million in 2025, then surged by 66.95% to $2.4 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $2.4 million, $1.5 million, and -$1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison